rs147522594
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 4P and 13B. PM1PP2PP3BP4_StrongBP6BS1BS2
The NM_001040142.2(SCN2A):c.4565G>C(p.Gly1522Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00059 in 1,613,220 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G1522G) has been classified as Likely benign.
Frequency
Consequence
NM_001040142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN2A | NM_001040142.2 | c.4565G>C | p.Gly1522Ala | missense_variant | 26/27 | ENST00000375437.7 | |
SCN2A | NM_001371246.1 | c.4565G>C | p.Gly1522Ala | missense_variant | 26/27 | ENST00000631182.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.4565G>C | p.Gly1522Ala | missense_variant | 26/27 | 5 | NM_001040142.2 | P1 | |
SCN2A | ENST00000631182.3 | c.4565G>C | p.Gly1522Ala | missense_variant | 26/27 | 5 | NM_001371246.1 |
Frequencies
GnomAD3 genomes ? AF: 0.000362 AC: 55AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000842 AC: 211AN: 250554Hom.: 4 AF XY: 0.00112 AC XY: 152AN XY: 135404
GnomAD4 exome AF: 0.000615 AC: 898AN: 1461080Hom.: 12 Cov.: 31 AF XY: 0.000791 AC XY: 575AN XY: 726808
GnomAD4 genome ? AF: 0.000355 AC: 54AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.000511 AC XY: 38AN XY: 74372
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | SCN2A: PP3, BS1, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 29, 2014 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 21, 2018 | This variant is associated with the following publications: (PMID: 26645390, 25818041, 9154907) - |
Seizures, benign familial infantile, 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | Aug 22, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 Benign:1Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpretted as Uncertain significance and reported on 05-24-2016 by Lab or GTR ID 506900. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 17, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 26, 2016 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at